SG
BIO icon

Stonnington Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Stonnington Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,700
Closed -$655K – 203
2022
Q3 		$655K Buy
+1,700
New +$848K 0.18% 109
2022
Q1 		– Sell
-712
Closed -$481K – 241
2021
Q4 		$481K Sell
712
-350
-33% -$262K 0.1% 166
2021
Q3 		$767K Buy
1,062
+250
+31% +$187K 0.17% 132
2021
Q2 		$546K Hold
812
– – 0.12% 164
2021
Q1 		$474K Buy
+812
New +$481K 0.11% 171

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Stonnington Group's BIO Position: Q4 2022 in Review

Stonnington Group sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2022, closing a stake of 1,700 shares — an estimated $655K sold.

Stonnington Group first reported a position in BIO in Q1 2021 and held it in 5 quarters. The position peaked at $767K in Q3 2021. 471 funds tracked by Wall St. Rank hold BIO as of Q4 2022.

  • Stonnington Group reported no remaining Bio-Rad Laboratories Class A position as of Q4 2022 after selling out during the quarter.
  • Stonnington Group sold 1,700 Bio-Rad Laboratories Class A shares in Q4 2022, an estimated $655K.
  • Stonnington Group first reported a position in Bio-Rad Laboratories Class A in Q1 2021 and held it in 5 quarters.
  • Stonnington Group's Bio-Rad Laboratories Class A position peaked at $767K in Q3 2021.
  • 471 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2022.

Based on Stonnington Group's 13F filing for Q4 2022, filed 11 Jan 2023.